GlassScriptPhysician profile
Donald M Kroe
NPI 1811963762
$9,474.50
in general payments reported to CMS, 2019-2025
44 companies · $2,519 in 2025
The $2,519 reported for 2025 was more than what 80% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $449 · 2021: $938 · 2022: $1,495 · 2023: $1,871 · 2024: $2,044 · 2025: $2,519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,417 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,416.73 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $1,485.80 | 2020-2025 | Wakix |
| Glaxosmithkline, LLC. | $1,468.82 | 2019-2025 | Trelegy Ellipta, Nucala, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,148.80 | 2020-2025 | Ofev, Jascayd, Spiriva Respimat |
| Astrazeneca Pharmaceuticals LP | $623.83 | 2019-2025 | Tezspire, Airsupra, Breztri |
| Grifols USA, LLC | $415.42 | 2021-2025 | Prolastin-C Liquid |
| Merck Sharp & Dohme LLC | $384.51 | 2019-2025 | Zerbaxa, Dificid, Recarbrio |
| Jazz Pharmaceuticals INC. | $297.24 | 2019-2024 | |
| Insmed, INC. | $276.40 | 2019-2025 | Arikayce, Brinsupri |
| Axsome Therapeutics, INC. | $272.88 | 2023-2025 | Sunosi |
| Regeneron Healthcare Solutions, INC. | $266.38 | 2021-2025 | Dupixent |
| United Therapeutics Corporation | $242.68 | 2021-2025 | Tyvaso, Tyvaso |
| Mylan Specialty L.P. | $234.47 | 2021-2023 | Yupelri |
| Ucb, INC. | $198.54 | 2019-2021 | |
| Inspire Medical Systems, INC. | $196.85 | 2024-2025 | Inspire |
| Pulmonx Corporation | $182.24 | 2022-2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $161.25 | 2025 | Ohtuvayre |
| Baxter Healthcare | $121.12 | 2022-2025 | Hillrom - Monarch Airway Clearance System, Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Phadia US INC. | $120.26 | 2021-2024 | Immunocap |
| Electromed, INC. | $117.44 | 2021-2024 | Smartvest |
| Actelion Pharmaceuticals US, INC. | $111.74 | 2020-2024 | Opsumit, Uptravi |
| Mallinckrodt Hospital Products INC. | $111.11 | 2020-2025 | Acthar |
| Genzyme Corporation | $108.97 | 2022-2024 | |
| Advanced Respiratory, INC | $103.27 | 2019-2021 | |
| Idorsia Pharmaceuticals US INC | $98.08 | 2022-2023 | Quviviq |
| Ani Pharmaceuticals, INC. | $80.06 | 2024-2025 | Purified Cortrophin Gel |
| Pfizer INC. | $77.54 | 2022-2024 | |
| Avadel Cns Pharmaceuticals, LLC | $77.29 | 2025 | Lumryz |
| Viatris Specialty LLC | $58.39 | 2025 | Yupelri |
| Bausch Health US, LLC | $46.84 | 2020-2021 | |
| Lilly USA, LLC | $46.60 | 2025 | Zepbound |
| Teva Pharmaceuticals USA, INC. | $45.18 | 2021 | |
| Philips North America LLC | $40.23 | 2025 | Sleep Service, Vest Therapy Und |
| Caris Mpi, INC. | $29.27 | 2025 | Mi Cancer Seek |
| Shionogi INC | $28.42 | 2022 | |
| La Jolla Pharmaceutical Company | $28.40 | 2023 | Giapreza |
| Vanda Pharmaceuticals INC. | $24.97 | 2023 | Hetlioz |
| Optinose US, INC. | $23.64 | 2025 | |
| Genentech USA, INC. | $22.02 | 2019 | |
| Exact Sciences Corporation | $19.52 | 2025 | Cologuard Collection Kit |
| Cumberland Pharmaceuticals, INC. | $17.13 | 2022 | |
| Vifor Pharma, INC. | $16.92 | 2024 | Zemaira |
| Seqirus USA INC | $15.70 | 2021 | |
| Paratek Pharmaceuticals, INC. | $15.13 | 2024 | Nuzyra |
| Janssen Pharmaceuticals, INC | $13.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Kroe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.